People · Operator
Named in public records as an officer, director or promoter · active 2007–2016 · Pharmaceuticals, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Adynxx, Inc. | — | Pharmaceuticals | Series B | $21.5M | $544.1M | 2007 |
| Corthera Inc | — | Other | Series B | $21.0M | $249.2M | 2009 |
| SiteOne Therapeutics, Inc. | — | Pharmaceuticals | Series A | $16.1M | $460.3M | 2015 |
Stan Abel at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Stan Abel on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Dennis Podlesak | 2 | 6 |
| Rick Orr | 2 | 5 |
| Lowell Sears | 2 | 3 |
| Heath Lukatch | 1 | 10 |
| Risa Stack | 1 | 9 |
| Brian Dovey | 1 | 7 |
| Joseph Zakrzewski | 1 | 6 |
| Scott Harris | 1 | 4 |
| Lowell E. Sears | 1 | 4 |
| Will Price | 1 | 4 |
| Eckard Weber | 1 | 3 |
| Thomas Wiggans | 1 | 3 |
| Rick E. Orr | 1 | 1 |
| Michael Ashley | 1 | 1 |
| Julien Mamet | 1 | 1 |
| George Barnett | 1 | 1 |
| Justin DuBois | 1 | 1 |
| George Miljanich | 1 | 1 |
| Donald Manning | 1 | 1 |
| Joseph E. Zakrzewski | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.